Association between third-space fluid and FEV1 in COPD patients

A. Jimenez Cepeda (saltillo, Mexico)

Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Session: What is new in COPD diagnosis and classification?
Session type: Thematic Poster
Number: 3627

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Jimenez Cepeda (saltillo, Mexico). Association between third-space fluid and FEV1 in COPD patients. 3627

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Closing volume predicts the FEV1 response to bronchodilators in patients with COPD
Source: Virtual Congress 2020 – Advances in lung function testing
Year: 2020


Association between weight loss and decline in FVC in patients with IPF
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019


Improvement in FEV1 after acute COPD exacerbations are driven more by changes in hyperinflation than changes in proximal airway volume
Source: International Congress 2015 – Clinical physiology: from airways, lung and respiratory muscles to dyspnoea in health and disease
Year: 2015

The effect of positive expiratory pressure for airway clearance on ventilation inhomogeneity in individuals with stable COPD and chronic sputum expectoration
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in COPD
Year: 2013


Changes in FEV1 and SpO2 in patients with severe and very severe COPD
Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases
Year: 2021

Comparison of pre and post-bronchodilator single-breath and re-breathe DLCO values amongst healthy, asthmatic and COPD subjects
Source: Annual Congress 2013 –New issues in lung function testing
Year: 2013


Relationship between FEV1 and PEF in patients with airways obstruction
Source: Eur Respir J 2004; 24: Suppl. 48, 120s
Year: 2004

Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012


Usefulness of FEV1/SVC to uncover airflow obstruction in subjects with preserved FEV1/FVC
Source: International Congress 2016 – Lung function and imaging: new findings and new approaches
Year: 2016

Osteoprotogerin plasma concentrations is correlate with forced expiratory volume at 1 second (FEV1) in patients with COPD
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013


Treatment with corticosteroids and yearly decline of forced expiratory flow (FEV1) in patients with severe chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Respiratory structure and function
Year: 2008


Association between nasal and bronchial resistance in patients with COPD
Source: International Congress 2018 – Innovations in equipment and their application
Year: 2018


Changes in FEV1 after recovery from COPD exacerbation are driven by heterogeneous regional changes in airway caliber and hyperinflation
Source: International Congress 2015 – Lung function: new findings and approaches
Year: 2015

FEV6 or FVC to detect airway obstruction in the community setting?
Source: Annual Congress 2007 - PG17 - Lung function measurement in the community
Year: 2007



Evaluation of the response of airway obstruction to short-acting inhaled broncodilators with using FIV1 and FEV1 in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 290s
Year: 2005

FEV6 as an alternative for FVC in detecting airflow obstruction in COPD patients undergoing six minute Walk test
Source: Annual Congress 2013 –The best posters in exercise testing and physical inactivity
Year: 2013


Primary care spirometry
Source: Eur Respir J 2008; 31: 197-203
Year: 2008



Changes of TNF-a level in bronchoalveolar fluid of patients with chronic obstructive pulmonary disease before and after the 30 days treatment with tiotropium bromide
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015

Changes in spirometry (FVC and FEV1) in a closed population of COPD patients using new standarized values for Mexican people
Source: Eur Respir J 2003; 22: Suppl. 45, 69s
Year: 2003

Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016